These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 209772)

  • 1. Epstein-Barr virus-associated antigens in nasopharyngeal carcinoma.
    Coates HL; Pearson GR; Neel HB; Weiland LH
    Arch Otolaryngol; 1978 Aug; 104(8):427-30. PubMed ID: 209772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal carcinoma in Japan--clinical evaluation of EBV serology and EBV-associated nuclear antigens test.
    Takimoto T; Furukawa M; Morishita K; Umeda R; Hatano M
    Auris Nasus Larynx; 1982; 9(3):151-63. PubMed ID: 6301414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunologic basis for detection of occult primary malignancies of the head and neck.
    Coates HL; Pearson GR; Neel HB; Weiland LH; Devine KD
    Cancer; 1978 Mar; 41(3):912-8. PubMed ID: 205337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
    Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
    Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
    Amador García JM; Mendoza Montero J; Expósito Hernández J; Salinero Hernández J; Esquivias López-Cuerpo J; Ballesteros García P
    Acta Otorrinolaringol Esp; 1992; 43(1):31-6. PubMed ID: 1316136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
    Cheng YC; Chen JY; Glaser R; Henle W
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6162-5. PubMed ID: 6255477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-EBV serologic tests for nasopharyngeal carcinoma.
    Neel HB; Pearson GR; Weiland LH; Taylor WF; Goepfert HH; Pilch BZ; Lanier AP; Huang AT; Hyams VJ; Levine PH; Henle G; Henle W
    Laryngoscope; 1980 Dec; 90(12):1981-90. PubMed ID: 6256597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck.
    Ringborg U; Henle W; Henle G; Ingimarsson S; Klein G; Silfversward C; Strander H
    Cancer; 1983 Oct; 52(7):1237-43. PubMed ID: 6309355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proper use of serum antibody titres against Epstein-Barr virus in nasopharyngeal carcinoma: IgA/virus capsid antigen for diagnosis and EBV-related nuclear antigen-2 for follow-up.
    Shimakage M; Dezawa T; Chatani M
    Acta Otolaryngol; 2000 Jan; 120(1):100-4. PubMed ID: 10779195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.
    Henle G; Henle W
    Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific Epstein-Barr virus antigen-induced lymphocyte response.
    Sundar SK; Ablashi DV; Kamaraju LS; Levine PH; Faggioni A; Armstrong GR; Pearson GR; Krueger GR; Hewetson JF; Bertram G; Sesterhenn K; Menezes J
    Int J Cancer; 1982 Apr; 29(4):407-12. PubMed ID: 6282765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx].
    Mazeron MC
    Bull Cancer Radiother; 1996; 83(1):3-7. PubMed ID: 8679277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
    Hewetson JF; Levine PH; Neubauer RH; Rabin H
    Int J Cancer; 1982 Nov; 30(5):581-5. PubMed ID: 6295966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.
    Neel HB; Pearson GR; Taylor WF
    Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):477-82. PubMed ID: 6093669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [IgG- and IgA-antibodies to the Epstein-Barr virus in the sera of patients with nasopharyngeal carcinoma in Cuba].
    Gurtsevich VE; Ruíz García R; Cuevas J; Le Riverand Morales E; Ascue M
    Vopr Virusol; 1979; (4):392-9. PubMed ID: 225887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of IgG and IgA antibodies to Epstein-Barr virus membrane antigen in sera from patients with nasopharyngeal carcinoma and from normal individuals.
    Zhu XX; Zeng Y; Wolf H
    Int J Cancer; 1986 May; 37(5):689-91. PubMed ID: 3009331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific Epstein-Barr virus serological response in patients with nasopharyngeal carcinoma detected by immunoblotting.
    Cevenini R; Donati M; Moroni A; Caliceti U; Rinaldi-Ceroni A; La Placa M
    Eur J Epidemiol; 1988 Sep; 4(3):301-5. PubMed ID: 2846341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunovirologic assessment of American patients with nasopharyngeal carcinoma and occult primary tumors.
    Coates HL; Neel HB; Pearson GR
    Otolaryngology; 1978; 86(3 Pt 1):ORL424-7. PubMed ID: 224361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.